Gamwell Rogers, MD
Otolaryngology · Atlanta, GANPI 1528269677
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Spirair, Inc. at 55.9% of the total. Reporting peaked in 2024 at $3,861 and has fallen 91.8% since, to $318 in 2025.
Across 49 payments — averaging $92.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spirair, Inc.$3K
- Acclarent, Inc$1K
- Sanofi$263
- Regeneron Healthcare Solutions, Inc.$160
- Intersect ENT, Inc.$93
- Integra Lifesciences Corporation$66
- plus $163 from 8 others
What the payments were for
- Consulting fees$2,57557%
- Travel & lodging$85719%
- Food & beverage$1,10024%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spirair, Inc. | 2 | $2,534 |
| Acclarent, Inc | 16 | $1,257 |
| Sanofi | 11 | $263 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| Intersect ENT, Inc. | 2 | $93 |
| Integra Lifesciences Corporation | 4 | $66 |
| Aerin Medical Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| AstraZeneca | 1 | $22 |
| Medtronic | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| GSK | 1 | $16 |
| Resmed Corp | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SeptAlign$5,000
- Acclarent Aera$125
How this compares
$4,536 in reported general payments places this provider in the 85th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 152 | $4,568 |
| Azelastine Hcl | 61 | $1,638 |
| Omeprazole | 81 | $476 |
| Cefdinir | 24 | $458 |
| Fluticasone Propionate | 42 | $303 |
| Famotidine | 14 | $202 |
| Montelukast Sodium | 12 | $172 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $157 |
| Doxycycline Hyclate | 14 | $128 |
| Clotrimazole | 14 | $100 |
| Zolpidem Tartrate | 17 | $92 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $54 |
| Prednisone | 29 | $47 |
| Lorazepam | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Atlanta
- Karen HoffmannAtlanta$223K
- Jose StolovitzkyAtlanta$81K
- Daniel CarothersAtlanta$8K
- Adam KleinAtlanta$8K
- Pradeep SinhaAtlanta$7K
- Kingsley ChinAtlanta$6K
- John SongAtlanta$6K
- James HamiltonAtlanta$5K
- Elizabeth ShawAtlanta$5K
- Michael KoriwchakAtlanta$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.